BULLFROG AI HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
BULLFROG AI HOLDINGS, INC. (BFRG) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price of $3.84 per share as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice · last filed 2026-05-14
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $3.84.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $4.10.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $3.98.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $3.90.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2026-03-31 | $3.84 10-Q · filed 2026-05-14 |
| 2025-12-31 | $4.10 10-K · filed 2026-03-19 |
| 2025-09-30 | $3.98 10-Q · filed 2025-11-14 |
| 2025-06-30 | $3.90 10-Q · filed 2025-08-13 |
| 2025-03-31 | $3.87 10-Q · filed 2026-05-14 |
| 2024-12-31 | $4.04 10-K · filed 2025-03-14 |
| 2024-09-30 | $4.06 10-Q · filed 2025-11-14 |
| 2024-06-30 | $4.03 10-Q · filed 2025-08-13 |
| 2024-03-31 | $4.02 10-Q · filed 2025-05-13 |
| 2023-12-31 | $4.01 10-K · filed 2024-03-29 |
| 2023-09-30 | $3.97 10-Q · filed 2024-11-08 |
| 2023-06-30 | $3.91 10-Q · filed 2024-08-07 |
| 2023-03-31 | $2.98 10-Q · filed 2024-05-10 |
| 2022-12-31 | $3.15 10-K · filed 2023-04-25 |
| 2021-12-31 | $3.36 10-K · filed 2023-04-25 |
| 2020-12-31 | $3.36 10-K · filed 2023-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |